Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
peyote
- Development stage
- Preclinical
- Lead developer
- Lophos Pharmaceuticals
- Modality
- Small Molecules
- Administration
- Oral
01
Overview
Peyote is a botanical/natural product derived from the *Lophophora williamsii* cactus, currently under development by Lophos Pharmaceuticals for various therapeutic applications. The product contains several alkaloids, most notably mescaline, a phenethylamine psychedelic that acts primarily as an agonist at the serotonin 5-HT2A receptor. Lophos is focusing on sustainable, ethical cultivation to address the endangered status of wild peyote populations while exploring its potential in treating mental health conditions such as anxiety and depression, as well as addiction and metabolic disorders like obesity. The company is developing both naturally-cultivated peyote for direct sale as a natural health product in Canada and standardized peyote-derived formulations for clinical research.
- Other names
- Lophophora williamsiimescaline-containing cactus
02
Targets
HTR2A (Serotonin receptor 5-HT2A)DRD3 (Dopamine receptor D3)DRD2 (Dopamine D2 Receptor)ADRA1A (α1A)HTR1A (Serotonin receptor 1A (5-hydroxytryptamine receptor 1A))HTR2C (5-hydroxytryptamine 2C receptor)DRD1 (Dopamine D1 Receptor)TAAR1 (Trace amine-associated receptor 1)HTR2B (5-Hydroxytryptamine Receptor 2B)
Beyond the preview
Go deeper on peyote.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on peyote.